Skip to main content
. 2020 Jan 1;11(3):678–685. doi: 10.7150/jca.37531

Table 3.

Association of age and LN positivity in China dataset.

Age, year N1 vs. N0 N2 vs. N0 N3a vs. N0 N3b vs. N0
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Unadjusted
T stage T1
18-39 1.112(0.481-2.573) .803 3.133(1.419-6.917) .005 3.615(1.307-10.004) .013 5.423(0.887-33.143) .067
40-49 1.700(0.924-3.126) .088 1.607(0.729-3.543) .240 1.757(0.622-4.964) .287 1.004(0.090-11.19) .997
50-59 1.114(0.627-1.978) .713 1.262(0.615-2.590) .525 0.278(0.058-1.326) .108 1.114(0.156-7.976) .915
60-69 Reference Reference Reference Reference
70+ 1.116(0.516-2.414) .781 1.741(0.734-4.131) .209 1.813(0.577-5.701) .309 / /
T stage T2
18-39 1.752(0.720-4.267) .217 1.188(0.423-3.340) .743 1.627(0.520-5.095) .403 13.667(2.548-73.304) .002
40-49 0.667(0.304-1.464) .313 0.617(0.265-1.437) .263 0.563(0.192-1.656) .297 / /
50-59 0.808(0.421-1.549) .520 1.261(0.674-2.360) .469 1.286(0.600-2.756) .518 1.500(0.244-9.213) .662
60-69 Reference Reference Reference Reference
70+ 1.364(0.655-2.841) .407 0.578(0.217-1.538) .273 0.792(0.265-2.360) .675 / /
T stage T3
18-39 1.356(0.587-3.130) .475 1.027(0.442-2.387) .951 2.576(0.172-5.662) .018 4.294(1.647-11.199) .003
40-49 0.795(0.365-1.732) .563 1.204(0.619-2.343) .585 0.923(0.409-2.083) .847 1.468(0.526-4.099) .463
50-59 0.820(0.464-1.449) .494 0.741(0.429-1.277) .280 0.908(0.495-1.668) .757 1.379(0.616-3.088) .435
60-69 Reference Reference Reference Reference
70+ 0.883(0.440-1.769) .725 0.686(0.343-1.372) .287 0.986(0.473-2.058) .971 0.986(0.343-2.838) .980
T stage T4
18-39 1.120(0.696-1.802) .642 1.171(0.726-1.801) .470 1.565(1.037-2.363) .033 2.255(1.439-3.535) .000
40-49 1.063(0.740-1.527) .740 0.768(0.542-1.089) .139 1.162(0.838-1.612) .369 1.460(1.004-2.122) .048
50-59 0.979(0.727-1.319) .891 0.867(0.659-1.140) .306 1.100(0.841-1.439) .486 1.171(0.851-1.610) .333
60-69 Reference Reference Reference Reference
70+ 0.901(0.617-1.317) .591 1.126(0.809-1.566) .483 0.847(0.597-1.203) .354 0.985(0.654-1.484) .942
Adjusted for covariates*
T stage T1
18-39 1.008(0.427-2.383) .985 3.204(1.395-7.359) .006 3.532(1.199-10.41) .022 12.039(1.365-106.2) .025
40-49 1.603(0.857-2.999) .139 1.608(0.714-3.623) .252 1.533(0.521-4.509) .437 1.757(0.135-22.80) .667
50-59 1.086(0.606-1.946) .781 1.239(0.594-2.583) .568 0.252(0.052-1.224) .087 1.441(0.168-12.371) .739
60-69 Reference Reference Reference Reference
70+ 1.168(0.529-2.580) .701 1.737(0.702-4.301) .233 2.263(0.667-7.683) .190 / /
T stage T2
18-39 1.829(0.733-4.567) .196 1.078(0.371-3.129) .890 1.453(0.449-4.704) .533 12.616(2.091-76.134) .006
40-49 0.667(0.297-1.498) .327 0.578(0.240-1.393) .222 0.483(0.159-1.474) .201 0.000E+00 .998
50-59 0.809(0.418-1.563) .527 1.293(0.675-2.475) .438 1.237(0.562-2.723) .597 1.193(0.182-7.836) .854
60-69 Reference Reference Reference Reference
70+ 1.311(0.622-2.763) .477 0.534(0.194-1.464) .223 0.703(0.229-2.161) .539 0.000E+00 .998
T stage T3
18-39 1.500(0.618-3.639) .370 1.106(0.454-2.695) .825 2.550(1.083-6.002) .032 3.703(1.299-10.55) .014
40-49 0.835(0.375-1.861) .659 1.222(0.613-2.436) .569 0.947(0.406-2.210) .900 1.487(0.507-4.360) .470
50-59 0.916(0.509-1.647) .769 0.756(0.433-1.321) .326 0.877(0.466-1.650) .684 1.227(0.525-2.869) .637
60-69 Reference Reference Reference Reference
70+ 0.909(0.446-1.851) .792 0.756(0.373-1.533) .438 1.078(0.503-2.311) .848 1.270(0.419-3.850) .673
T stage T4
18-39 1.235(0.760-2.009) .394 1.215(0.783-1.884) .385 1.631(1.066-2.495) .024 2.267(1.393-3.690) .001
40-49 1.129(0.782-1.629) .517 0.785(0.552-1.117) .179 1.146(0.819-1.601) .426 1.326(0.885-1.988) .172
50-59 0.999(0.740-1.349) .994 0.870(0.660-1.148) .325 1.080(0.821-1.419) .583 1.160(0.826-1.630) .392
60-69 Reference Reference Reference Reference
70+ 0.920(0.628-1.349) .670 1.149(0.824-1.603) .412 0.901(0.631-1.287) .566 1.206(0.777-1.872) .404

CI = confidence interval; Ref = referent; OR = odds ratio. *Covariates include log (number of lymph nodes examined), year of diagnosis, differentiation, sex, type of surgery.